We are live on
!
Find out more
SCM
Suvretta Capital Management Portfolio holdings
AUM
$3.92B
1-Year Est. Return
86.67%
This Fund
S&P 500
This Quarter
Est. Return
-6.15%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$943M
AUM Growth
-$1.17B
(-55%)
Cap. Flow
-$1.11B
Cap. Flow
% of AUM
-118.05%
Top 10 Holdings %
Top 10 Hldgs %
91.98%
Holding
40
New
6
Increased
5
Reduced
6
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.5M |
| 2 |
Pfizer
PFE
|
+$21.5M |
| 3 |
Liberty Global Class C
LBTYK
|
+$19.1M |
| 4 |
Restaurant Brands International
QSR
|
+$9.56M |
| 5 |
Bausch Health
BHC
|
+$8.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Air Products & Chemicals
APD
|
+$135M |
| 2 |
Cheniere Energy
LNG
|
+$135M |
| 3 |
PPG Industries
PPG
|
+$108M |
| 4 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$102M |
| 5 |
NextEra Energy
NEE
|
+$84.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.63% |
| 2 | Communication Services | 25.12% |
| 3 | Consumer Staples | 10.94% |
| 4 | Consumer Discretionary | 10.21% |
| 5 | Technology | 7.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $156M | 16.51% |
573,041
+92,800
| +19% | +$28.5M |
|
|
2
Liberty Global Class C
LBTYK
$3.38B
| $130M | 13.75% |
3,643,142
+472,432
| +15% | +$19.1M |
|
3
Constellation Brands
STZ
$22.9B
| $103M | 10.94% |
824,318
+41,300
| +5% | +$5.09M |
|
|
TWC
4
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $94.4M | 10.01% |
526,300
-113,200
| -18% | -$21.1M |
|
5
CALL
Charter Communications
CHTR
$15.9B
| $87.9M | 9.32% |
+500,000
| New | +$91.3M |
|
|
6
Restaurant Brands International
QSR
$25.7B
| $75.2M | 7.97% |
2,093,035
+241,300
| +13% | +$9.56M |
|
7
Adobe
ADBE
$93.3B
| $70.8M | 7.5% |
860,500
-400,100
| -32% | -$32.4M |
|
|
8
Bausch Health
BHC
$1.75B
| $63.3M | 6.71% |
354,750
+34,400
| +11% | +$8.02M |
|
9
Aramark
ARMK
$14.8B
| $63.1M | 6.69% |
2,948,804
-1,719,062
| -37% | -$39.3M |
|
|
AGN
10
CALL
DELISTED
Allergan plc
AGN
| $24.5M | 2.59% |
+90,000
| New | +$27.6M |
|
|
11
Pfizer
PFE
$141B
| $20M | 2.12% |
+671,398
| New | +$21.5M |
|
12
Medtronic
MDT
$107B
| $19.8M | 2.1% |
295,500
-223,600
| -43% | -$16.5M |
|
13
Five Below
FIVE
$11.3B
| $19.2M | 2.04% |
572,450
-88,050
| -13% | -$3.2M |
|
|
14
Charter Communications
CHTR
$15.9B
| $7.3M | 0.77% |
+41,501
| New | +$7.57M |
|
15
Liberty Latin America Class A
LILA
$1.48B
| $5.56M | 0.59% |
+257,905
| New | +$6.57M |
|
16
Yum! Brands
YUM
$40.6B
| $1.88M | 0.2% |
+32,689
| New | +$1.98M |
|
17
Labcorp
LH
$23.1B
| $1.88M | 0.2% |
20,137
-647,068
| -97% | -$66.9M |
|
18
Agilent Technologies
A
$36.8B
| – | – |
-433,800
| Closed | -$16.7M |
|
19
Apple
AAPL
$4.8T
| – | – |
-1,757,404
| Closed | -$55.1M |
|
|
20
Air Products & Chemicals
APD
$66.1B
| – | – |
-1,065,758
| Closed | -$135M |
|
21
Booking.com
BKNG
$139B
| – | – |
-750,150
| Closed | -$34.5M |
|
22
CALL
Cigna
CI
$75.1B
| – | – |
-260,000
| Closed | -$42.1M |
|
|
23
Cigna
CI
$75.1B
| – | – |
-267,800
| Closed | -$43.4M |
|
24
Energy Transfer Partners
ET
$69.8B
| – | – |
-46,200
| Closed | -$1.48M |
|
25
Expedia Group
EXPE
$31.8B
| – | – |
-157,300
| Closed | -$17.2M |
|
Similar funds
MIM
AA
DACG
CCM
BCP
AS
MSI
FLSM
Suvretta Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Suvretta Capital Management held 40 positions worth $943M, down 55% from $2.12B the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Suvretta Capital Management withdrew a net $1.11B in Q3 2015, closing 23 positions and reducing 6 holdings. Its most notable exit was Air Products & Chemicals, an estimated $135M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 20% a quarter earlier, followed by Communication Services and Consumer Staples.
Against the trend, Suvretta Capital Management opened a new position in Pfizer worth $20M.
- Suvretta Capital Management's largest Q3 2015 buy was Pfizer: 671,398 shares worth $20M.
- Suvretta Capital Management added most to Allergan plc in Q3 2015, an estimated $28.5M increase.
- Suvretta Capital Management's biggest Q3 2015 reduction was Labcorp, cutting an estimated $66.9M.
- Suvretta Capital Management fully exited Air Products & Chemicals in Q3 2015, selling an estimated $135M.
- Suvretta Capital Management's ten largest holdings make up 92% of its $943M portfolio in Q3 2015.
- Suvretta Capital Management opened 6 new positions and closed 23 in Q3 2015.
- Suvretta Capital Management's portfolio value fell 55% quarter-over-quarter to $943M.
Based on Suvretta Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.